NIH Foregut Team: Dedicated to clinical research and care of patients with cancers of the esophagus, stomach, pancreas, liver and bile ducts

Authors

• NIH Foregut Team

Abstract

The foregut is a section of the upper gastrointestinal tract that includes the esophagus, stomach, liver, pancreas and bile ducts. Foregut cancers affect approximately 140,000 people per year in the United States. While each of these cancer types is not among the most common cancers, they are the most difficult to treat. Expertise in both diagnosis and treatment is necessary to provide patients with the best possible outcomes. Patients require experts in the fields of surgical oncology, gastroenterology, medical oncology, radiation therapy, nutrition, interventional radiology and more. The mission of the NIH Foregut Team is to deliver high-quality care to patients in the setting of innovative clinical trials for tumors of the foregut. Members of our team have partnered together in patient care for ten years or more. It is our seamless cooperation and integrated approach to cancer treatment and research that is the greatest benefit to our patients. Modest progress has been made in the treatment of foregut cancers over the past few decades. To help address the problems facing patients and the physicians who treat them, the NIH Foregut Team includes leaders in cancer treatment and research who conduct studies that focus on new approaches to the diagnosis and treatment of cancer. In addition, this team of specialists also studies and treats patients with conditions that are known to lead to cancer. We have recently launched a website to provide information about ongoing studies at NIH and recent progress made by our team. https://ccr.cancer.gov/thoracic-and-gastrointestinal-oncology-branch/foregut-team

Scientific Focus Area: Research Support Services

This page was last updated on Friday, March 26, 2021